Author | Year | Sample size | FSS | RS | Age group (yr) | Histology | Adjuvant chemo/radio therapy | Stage | Grade | Follow-up (yr) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FSS | RS | FSS | RS | FSS | RS | FSS | RS | FSS | RS | FSS | RS | |||||
Crafton et al | 2020 | 1262 | 3823 | Unilateral salpingo-oophorectomy and uterine preservation | Bilateral salpingo-oophorectomy or hysterectomy | Range: 15–44 | Mucinous: 461 Endometroid: 418 Serous: 309 Clear cell: 368 | Mucinous: 682 Endometroid: 1308 Serous: 1465 Clear cell: 368 | Y:651 N: 611 | Y:2569 N: 1254 | IA/B: 590 IC: 321 II-IV: 351 | IA/B: 1242 IC: 792 II-IV: 1789 | 1or2:956 3:306 | 1or2:2339 3:1484 | 4.61 | |
Jiang et al | 2017 | 52 | 56 | Ipsilateral adnexectomy and biopsy or wedge excision of contralateral ovary | Hysterectomy and bilateral adnexectomy | 251 | 351 | Mucinous: 38 Endometroid: 1 Serous: 1 Clear cell: 2 | Mucinous: 14 Endometroid: 16 Serous: 8 Clear cell: 18 | Y:33 N:19 | Y:50 N:6 | IA/B: 19 IC1: 24 IC2/3:9 | IA/B: 17 IC1: 31 IC2/3:8 | 1:45 2:4 3:1 | 1:27 2:8 3:3 | 6.91 |
Frusico et al | 2016 | 242 | 789 | Cystectomy or unilateral adnexectomy and complete peritoneal staging | Hysterectomy, bilateral salpingo-oophorectomy | 31.32 | 53.12 | Mucinous: 101 Endometroid: 55 Serous: 62 Clear cell: 17 Others:7 | Mucinous: 152 Endometroid: 203 Serous: 237 Clear cell: 134 Others:56 | Y:103 N:139 | Y:494 N:295 | IA: 129 IB: 2 IC1: 57 IC2/3:46 | IA: 337 IB: 63 IC1: 136 IC2/3:223 | 1:145 2:69 3:27 | 1:225 2:225 3:320 | 11.91 |
Lee et al | 2015 | 35 | 55 | Unilateral salpingo-oophorectomy with surgical exploration. Surgical staging was optional | Patients other than those undergoing FS surgery | 28.62 | 50.32 | Mucinous:35 | Mucinous:55 | Y:14 N:21 | Y:26 N:29 | IA: 21 IB: 0 IC: 13 II: 1 | IA: 34 IB: 1 IC: 17 II: 3 | 1:27 2:5 3:1 NK:2 | 1:34 2:15 3:2 NK:4 | 8.61 |
Ditto et al | 2015 | 70 | 237 | Preservation of the uterus, of at least one tube and the contralateral ovary | Radical comprehensive staging | 301 | 511 | Mucinous: 36 Endometroid: 8 Serous: 18 Others: 8 | Mucinous: 2 Endometroid: 71 Serous: 83 Others: 48 | Y:26 N:44 | Y:169 N:68 | IA: 46 IB: 2 IC: 15 II-III: 6 | IA: 95 IB: 21 IC: 45 II-III: 76 | 1:36 2:24 3:9 | 1:64 2:80 3:85 | FSS:6.41 RS:6.81 |
Kajiyama et al | 2011 | 74 | 498 | Conservation of the uterus and contralateral ovary and fallopian tube with at least a full peritoneal staging | Hysterectomy, and bilateral salpingo-oophorectomy with peritoneal staging | ≤40 | < 40 and > 40 age groups | Mucinous: 43 Endometroid: 14 Serous: 4 Clear cell: 13 Others:0 | Mucinous: 107 Endometroid: 114 Serous: 60 Clear cell: 199 Others: 18 | Y:54 N:20 | Y:392 N:106 | IA: 36 IB: 1 IC1: 21 IC2/3:16 | IA: 155 IB: 6 IC1: 145 IC2/3:192 | 1or2:57 3:4 | 1or2:266 3:33 | FSS:5.21 RS:5.51 |
Wright et al | 2009 | 432 | 754 | Unilateral oophorectomy | Bilateral oophorectomy | < 25:666 25–35: 181 36–50:185 | < 25:64 25–35: 68 36–50:682 | Mucinous: 211 Endometroid: 90 Serous: 98 Clear cell: 33 | Mucinous: 188 Endometroid: 285 Serous: 160 Clear cell: 121 | Y: 426 N:3 NK:3 | Y: 720 N:22 NK:12 | 1A:370 1C:62 | 1A:551 1C:203 | 1:157 2:92 3:37 | 1:236 2:196 3:104 | NS (5-year survival reported) |
Zanetta et al | 1997 | 56 | 43 | Unilateral oophorectomy and uterine preservation and surgical staging | Hysterectomy, and bilateral salpingo-oophorectomy with surgical staging | 292 | 342 | Mucinous: 23 Endometroid: 13 Serous: 18 Clear cell: 0 Others:2 | Mucinous: 10 Endometroid: 10 Serous: 16 Clear cell: 5 Others:02 | Y:16 N:40 | Y:10 N:33 | IA: 32 IB: 2 IC: 22 | IA: 27 IB: 3 IC: 13 | 1:35 2:14 3:7 | 1:21 2:15 3:7 | 7.831 |